{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:53:54Z","timestamp":1775717634672,"version":"3.50.1"},"reference-count":32,"publisher":"Scientific Scholar","content-domain":{"domain":["cytojournal.com"],"crossmark-restriction":true},"short-container-title":["Cytojournal"],"abstract":"\n Objectives:<\/jats:title>\n The role of fibrinogen-like protein 1 (FGL1) in the immune microenvironment in bladder cancer has been extensively studied, but the specific regulatory pathways require further investigation.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n \n The overexpression vector of FGL1 or small interfering RNA was transfected into RT4 cells, and cell growth was observed. Tumor cells with altered FGL1 expression were co-incubated with peripheral blood mononuclear cells to simulate the immune microenvironment of bladder cancer\n in vitro<\/jats:italic>\n , and the number and function of immune cells were monitored. The potential interacting proteins of FGL1 were predicted using an online bioinformatics database. Fibronectin 1 (FN1) was selected as the follow-up research object and was overexpressed or knocked down to explore its effect on tumor cell growth and immune microenvironment. A mouse model of transplanted tumor\n in vitro<\/jats:italic>\n was established to explore FGL1 knockdown on tumor growth and immune microenvironment\n in vivo<\/jats:italic>\n .\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n FGL1 was abnormally overexpressed in bladder cancer and enhanced RT4 cells\u2019 migration, invasion, and proliferation. Its knockdown inhibited tumor cell growth. FGL1 decreased CD4 and CD8+T cell proportion, increased the number of Treg cells, promoted CD8+T cell apoptosis, inhibited interferon-gamma, and upregulated the secretion level of interleukin-10. Its knockdown had the opposite effect. FN1 was identified as an interacting protein of FGL1 and was positively regulated by FGL1 to promote the growth of RT4 cells. In the FGL1-induced tumor immunosuppressive microenvironment, blocking FN1 reversed the situation.\n In vivo<\/jats:italic>\n studies showed that FGL1 silencing inhibited the growth of subcutaneously transplanted tumors in mice, which was related to the inhibition of FGL1 and FN1 expression.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n FGL1 promotes bladder cancer immune evasion by upregulating FN1. Our results provide a new reference for the immunotherapy of bladder cancer.<\/jats:p>\n <\/jats:sec>","DOI":"10.25259\/cytojournal_80_2025","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:04:37Z","timestamp":1775714677000},"page":"25","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fibrinogen-like protein 1 induces the formation of an immunosuppressive microenvironment by upregulating fibronectin 1 to promote immune evasion in bladder cancer"],"prefix":"10.25259","volume":"23","author":[{"given":"Keyao","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Qingdao University, Qingdao, China"},{"name":"Department of Urology, Yantaishan Hospital, Yantai, Shandong, China,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Yantaishan Hospital, Yantai, Shandong, China,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Yantaishan Hospital, Yantai, Shandong, China,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijiang","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"10.25259\/Cytojournal_80_2025\/ref-1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.25259\/Cytojournal_80_2025\/ref-2","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","article-title":"The global burden of urinary bladder cancer: An update","volume":"38","author":"Richters","year":"2020","journal-title":"World J Urol"},{"key":"10.25259\/Cytojournal_80_2025\/ref-3","doi-asserted-by":"publisher","first-page":"04109","DOI":"10.7189\/jogh.13.04109","article-title":"The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040","volume":"13","author":"Zhang","year":"2023","journal-title":"J Glob Health"},{"key":"10.25259\/Cytojournal_80_2025\/ref-4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"10.25259\/Cytojournal_80_2025\/ref-5","doi-asserted-by":"publisher","first-page":"935.e9","DOI":"10.1016\/j.urolonc.2020.08.014","article-title":"Hospital-specific probability of cystectomy affects survival from muscle-invasive bladder cancer","volume":"38","author":"Ripping","year":"2020","journal-title":"Urol Oncol"},{"key":"10.25259\/Cytojournal_80_2025\/ref-6","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00262-023-03376-9","article-title":"Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer","volume":"72","author":"Semeniuk-Wojtas","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"10.25259\/Cytojournal_80_2025\/ref-7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/CJI.0000000000000466","article-title":"Immune Co-inhibitory receptors CTLA-4, PD-1, TIGIT, LAG-3, and TIM-3 in upper tract urothelial carcinomas: A large cohort study","volume":"46","author":"Jin","year":"2023","journal-title":"J Immunother"},{"key":"10.25259\/Cytojournal_80_2025\/ref-8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13045-021-01161-8","article-title":"Fibrinogen-like protein 1 (FGL1): The next immune checkpoint target","volume":"14","author":"Qian","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.25259\/Cytojournal_80_2025\/ref-9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3892\/ijo.2019.4838","article-title":"Loss of FGL1 induces epithelialmesenchymal transition and angiogenesis in LKB1 mutant lung adenocarcinoma","volume":"55","author":"Bie","year":"2019","journal-title":"Int J Oncol"},{"key":"10.25259\/Cytojournal_80_2025\/ref-10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12931-020-01477-y","article-title":"FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer","volume":"21","author":"Sun","year":"2020","journal-title":"Respir Res"},{"key":"10.25259\/Cytojournal_80_2025\/ref-11","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1038\/s41467-024-50262-8","article-title":"Loss of tumor suppressors promotes inflammatory tumor microenvironment and enhances LAG3+T cell mediated immune suppression","volume":"15","author":"Zahraeifard","year":"2024","journal-title":"Nat Commun"},{"key":"10.25259\/Cytojournal_80_2025\/ref-12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cell.2018.11.010","article-title":"Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-3","volume":"176","author":"Wang","year":"2019","journal-title":"Cell"},{"key":"10.25259\/Cytojournal_80_2025\/ref-13","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.1038\/s41467-023-42332-0","article-title":"The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"10.25259\/Cytojournal_80_2025\/ref-14","doi-asserted-by":"publisher","first-page":"e164528","DOI":"10.1172\/JCI164528","article-title":"Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma","volume":"133","author":"Lin","year":"2023","journal-title":"J Clin Invest"},{"key":"10.25259\/Cytojournal_80_2025\/ref-15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/cei\/uxad137","article-title":"FGL1 in plasma extracellular vesicles is correlated with clinical stage of lung adenocarcinoma and anti-PD-L1 response","volume":"216","author":"Zhang","year":"2024","journal-title":"Clin Exp Immunol"},{"key":"10.25259\/Cytojournal_80_2025\/ref-16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jama.2024.22530","article-title":"The 2024 revision to the declaration of Helsinki: Modern ethics for medical research","volume":"333","author":"Bibbins-Domingo","year":"2025","journal-title":"JAMA"},{"key":"10.25259\/Cytojournal_80_2025\/ref-17","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s11255-023-03517-0","article-title":"Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities","volume":"55","author":"Cano Garcia","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"10.25259\/Cytojournal_80_2025\/ref-18","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/s41590-022-01238-7","article-title":"LAG3 ectodomain structure reveals functional interfaces for ligand and antibody recognition","volume":"23","author":"Ming","year":"2022","journal-title":"Nat Immunol"},{"key":"10.25259\/Cytojournal_80_2025\/ref-19","doi-asserted-by":"publisher","first-page":"7125","DOI":"10.1002\/cam4.3151","article-title":"Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti-Lag-3 via reducing FGL1 expression","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med"},{"key":"10.25259\/Cytojournal_80_2025\/ref-20","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3892\/mmr.2018.9097","article-title":"Fibrinogenlikeprotein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis","volume":"18","author":"Zhang","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.25259\/Cytojournal_80_2025\/ref-21","doi-asserted-by":"publisher","first-page":"106113","DOI":"10.1016\/j.intimp.2019.106113","article-title":"The co-expression characteristics of LAG3 and PD-1 on the T cells of patients with breast cancer reveal a new therapeutic strategy","volume":"78","author":"Du","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.25259\/Cytojournal_80_2025\/ref-22","doi-asserted-by":"publisher","first-page":"e009358","DOI":"10.1136\/jitc-2024-009358","article-title":"Impact of LAG-3\/FGL1 pathway on immune evasive contexture and clinical outcomes in advanced urothelial carcinoma","volume":"12","author":"Yoshida","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.25259\/Cytojournal_80_2025\/ref-23","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.2174\/1568026622666220615152647","article-title":"Recent progress on the role of fibronectin in tumor stromal immunity and immunotherapy","volume":"22","author":"Peng","year":"2022","journal-title":"Curr Top Med Chem"},{"key":"10.25259\/Cytojournal_80_2025\/ref-24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.addr.2020.09.005","article-title":"Fibronectin in development and wound healing","volume":"170","author":"Patten","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.25259\/Cytojournal_80_2025\/ref-25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2019.08.021","article-title":"MicroRNA-1 suppresses glioblastoma in preclinical models by targeting fibronectin","volume":"465","author":"Yang","year":"2019","journal-title":"Cancer Lett"},{"key":"10.25259\/Cytojournal_80_2025\/ref-26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13058-023-01629-0","article-title":"A positive feedback loop driven by fibronectin and IL-1\u03b2 sustains the inflammatory microenvironment in breast cancer","volume":"25","author":"Tunali","year":"2023","journal-title":"Breast Cancer Res BCR"},{"key":"10.25259\/Cytojournal_80_2025\/ref-27","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1080\/09168451.2020.1813543","article-title":"The anti-tumor effect of ursolic acid on papillary thyroid carcinoma via suppressing Fibronectin-1","volume":"84","author":"Cao","year":"2020","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.25259\/Cytojournal_80_2025\/ref-28","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1007\/s12011-022-03510-1","article-title":"Fibronectin 1 as a key gene in the genesis and progression of cadmium-related bladder cancer","volume":"201","author":"Zhang","year":"2023","journal-title":"Biol Trace Element Res"},{"key":"10.25259\/Cytojournal_80_2025\/ref-29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12885-020-06740-5","article-title":"In silico analysis of the immune microenvironment in bladder cancer","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"key":"10.25259\/Cytojournal_80_2025\/ref-30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","article-title":"CD4(+) T cells in cancer","volume":"4","author":"Speiser","year":"2023","journal-title":"Nat Cancer"},{"key":"10.25259\/Cytojournal_80_2025\/ref-31","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1038\/s41598-023-33508-1","article-title":"Tumor resident memory CD8 T cells and concomitant tumor immunity develop independently of CD4 help","volume":"13","author":"Medler","year":"2023","journal-title":"Sci Rep"},{"key":"10.25259\/Cytojournal_80_2025\/ref-32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T cells in tumor microenvironment: New mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol Cancer"}],"container-title":["Cytojournal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cytojournal.com\/fibrinogen-like-protein-1-induces-the-formation-of-an-immunosuppressive-microenvironment-by-upregulating-fibronectin-1-to-promote-immune-evasion-in-bladder-cancer\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cytojournal.com\/fibrinogen-like-protein-1-induces-the-formation-of-an-immunosuppressive-microenvironment-by-upregulating-fibronectin-1-to-promote-immune-evasion-in-bladder-cancer\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:04:37Z","timestamp":1775714677000},"score":1,"resource":{"primary":{"URL":"https:\/\/cytojournal.com\/fibrinogen-like-protein-1-induces-the-formation-of-an-immunosuppressive-microenvironment-by-upregulating-fibronectin-1-to-promote-immune-evasion-in-bladder-cancer\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":32,"alternative-id":["10.25259\/Cytojournal_80_2025"],"URL":"https:\/\/doi.org\/10.25259\/cytojournal_80_2025","relation":{},"ISSN":["1742-6413","0974-5963"],"issn-type":[{"value":"1742-6413","type":"electronic"},{"value":"0974-5963","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"article-number":"25"}}